How many employees does Dechra Pharmaceuticals have this year?
Dechra Pharmaceuticals has 1,808 undefined employees this year.
In 2024, Dechra Pharmaceuticals employed 1,808 people, a 0% change from the 1,808 number of employees in the previous year.
Dechra Pharmaceuticals's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Dechra Pharmaceuticals's operational capacity and future potential.
Assessing Dechra Pharmaceuticals's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Dechra Pharmaceuticals's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Fluctuations in Dechra Pharmaceuticals’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Dechra Pharmaceuticals has 1,808 undefined employees this year.
Compared to the previous year, Dechra Pharmaceuticals had 0% more employees.
The number of employees has a direct impact on the efficiency and productivity of Dechra Pharmaceuticals. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
The number of employees can also have an impact on investors of Dechra Pharmaceuticals, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
An increase in equity of Dechra Pharmaceuticals can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
A reduction in equity of Dechra Pharmaceuticals can impair its financial stability and decrease its ability to fulfill future investments and obligations.
Some factors that can influence the equity of Dechra Pharmaceuticals include, among others, revenue development, profit and loss statement, dividend payments, and investments.
The equity of Dechra Pharmaceuticals is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
The number of employees at Dechra Pharmaceuticals can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
In recent years, the number of employees at Dechra Pharmaceuticals has changed by 0.
Dechra Pharmaceuticals currently has 1,808 undefined employees.
The number of employees is important for investors of Dechra Pharmaceuticals as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
To change the number of employees, Dechra Pharmaceuticals can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
Over the past 12 months, Dechra Pharmaceuticals paid a dividend of 0.25 GBP . This corresponds to a dividend yield of about 0.65 %. For the coming 12 months, Dechra Pharmaceuticals is expected to pay a dividend of 0.25 GBP.
The current dividend yield of Dechra Pharmaceuticals is 0.65 %.
Dechra Pharmaceuticals pays a quarterly dividend. This is distributed in the months of November, April, November, April.
Dechra Pharmaceuticals paid dividends every year for the past 25 years.
For the upcoming 12 months, dividends amounting to 0.25 GBP are expected. This corresponds to a dividend yield of 0.65 %.
Dechra Pharmaceuticals is assigned to the 'Health' sector.
To receive the latest dividend of Dechra Pharmaceuticals from 4/13/2023 amounting to 0.125 GBP, you needed to have the stock in your portfolio before the ex-date on 3/9/2023.
The last dividend was paid out on 4/13/2023.
In the year 2023, Dechra Pharmaceuticals distributed 0.449 GBP as dividends.
The dividends of Dechra Pharmaceuticals are distributed in GBP.
The Dechra Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic
Our stock analysis for Dechra Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dechra Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.